Blacksmith Medicines, Inc. (Blacksmith), a leading biopharma dedicated to discovering and developing therapeutics targeting metalloenzymes, today announced that the United States Patent and Trademark ...

Basel-based BioVersys stands to receive CHF 5 million upfront under the terms of the deal, which could be worth up to CHF 479 ...

A brain abscess is a rare but life-threatening infection. Learn how advances in imaging, surgery, and diagnostics are ...

Anaerobic bacteria were among the first life forms on earth and existed at a time when there was no oxygen in the atmosphere. While many organisms ...

Iterum Therapeutics plc (Nasdaq: ITRM) ('Iterum” or the 'Company”), a company committed to delivering next generation oral and IV antibiotics to address infections caused by multi-drug resistant ...

Cyclic-di-AMP is a broadly conserved nucleotide second messenger that is critical for growth and virulence in Gram-positive bacteria. Genetic, cell biological and biophysical analyses reveal that ...

Explore the potential of CTX-09 against MDR bacteria and its effectiveness in addressing antibiotic resistance challenges.

The antimicrobial’s global rollout gets a boost with standardised susceptibility testing specifications for clinicians.

Bacterial genetics is the study of the mechanisms of heritable information in bacteria, their chromosomes, plasmids, transposons and phages. Techniques that have enabled this discipline are ...

As more people - and their respective pathogens - travel to space, it is likely that this is only the beginning.

Alembic to expand their U.S. commercial portfolio with FDA-approved PIVYA for the treatment of women with uncomplicated ...